Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Directorate Change

7 Jun 2017 07:00

RNS Number : 3396H
Galliford Try PLC
07 June 2017
Β 

GALLIFORD TRY PLC

Β 

7 JUNE 2017

Β 

NOTIFICATION OF FUTURE BOARD AND COMMITTEE CHANGES & APPOINTMENT OF NON-EXECUTIVE DIRECTOR

Β 

Galliford Try, the housebuilding, regeneration and construction group, is pleased to announce the appointment of Jeremy Townsend as a non-executive director. The appointment will formally commence with effect 1 September 2017.

Β 

Andrew Jenner, currently chair of the audit committee, has notified the Board of his intention not to seek re-election at the 2017 annual general meeting and to therefore step down later this year having completed nine years on the Board.

Β 

Also with effect from 1 September 2017, Peter Ventress will assume the chairmanship of the nomination committee. Terry Miller will continue to be a member of the committee.

Β 

Peter Ventress, Chairman, commented: "I am delighted to welcome Jeremy to Galliford Try as a non-executive director. Jeremy's appointment will further strengthen our independence and the experience of the Board as well as ensure a smooth transition for Andrew's departure. The Board looks forward to Jeremy quickly establishing himself in the new role, and to benefiting from his extensive corporate and sector experience. Jeremy will assume the role of chair of the audit committee on Andrew stepping down.Β 

Β 

On behalf of the Group I would like to thank Andrew for his valuable contributions as a director and excellent chairmanship of the audit committee in overseeing a time of significant change and growth during his extensive time on the Board.

Β 

I would also like to express my thanks on behalf of the Group for Terry's service as chair of the nomination committee during a time of major change at Board and senior management level over the past three years."

Β 

On appointment Jeremy will also become a member of the remuneration and nomination committees.

Β 

Jeremy Townsend Biography

Jeremy is currently the Chief Financial Officer of Rentokil Initial plc following appointment in August 2010. He is a Fellow of the Institute of Chartered Accountants of England and Wales and a member of the Accounting Council of the Financial Reporting Council. Previously, Jeremy was Finance Director at Mitchells & Butlers Plc and prior to that held various finance roles at J Sainsbury Plc including Corporate Finance Director. Jeremy began his career in audit and corporate finance at Ernst & Young.

Β 

There are no other disclosures required in respect of Jeremy Townsend pursuit to Rule 9.6.13 of the Listing Rules.

Β 

For further enquiries, please contact:

Β 

Galliford Try plc Kevin Corbett, General Counsel & Company Secretary 01895 855001

Β 

Equitory Clara Melia, Investor Relations 07748 171236

Β 

Notes to Editors

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2016, the Group generated revenue of Β£2.7 billion.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAQQLFBDQFLBBB
Date   Source Headline
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.